Adjuvant Radiotherapy May Extend Survival in Lymph Node-Positive Prostate Cancer

After radical prostatectomy, radiotherapy plus male hormone suppression therapy(androgen deprivation therapy) was shown in prostate cancer patients to extend survival by a study in Cancer .
For prostate cancer involving adjacent lymph nodes without spread to other organs, initial treatment options are surgery and radiotherapy. Surgery and extended lymph node dissection are increasingly preferred, but the need for postoperative preventive (adjuvant) treatment is controversial. Studies support radiotherapy after extended groin lymph node clearance in selected patients, but this approach has not entered routine practice.
The Study
Data were analyzed from patients undergoing radical prostatectomy between 2003 and 2011 with documented groin-node spread: 2569 prostate cancer patients.
The 5-year survival rate was %87 with radiotherapy versus %82 without it (P = .007).
With no randomized trial yet available, these findings may guide decisions for node-positive prostate cancer without spread elsewhere. Large prospective studies are needed for confirmation.
Sources
The role of adjuvant radiotherapy in pathologically lymph node positive prostate cancer.
Cancer. 2016 Nov 8. doi: 10.1002/cncr.30373
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.